Robert James Wills Buys 10,000 Shares of Alpha Cognition (NASDAQ:ACOG) Stock

Alpha Cognition Inc. (NASDAQ:ACOG) Director Robert James Wills bought 10,000 shares of Alpha Cognition stock in a transaction on Friday, August 21st. The shares were acquired at an average cost of $9.62 per share, for a total transaction of $96,200.00. Following the completion of the acquisition, the director directly owned 32,241 shares in the company, valued at approximately $310,158.42. The trade was a 44.96% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Alpha Cognition Stock Performance

Shares of NASDAQ ACOG opened at $9.75 on Wednesday. Alpha Cognition Inc. has a 52-week low of $4.50 and a 52-week high of $10.14. The firm has a 50 day moving average price of $8.20 and a two-hundred day moving average price of $6.73. The stock has a market cap of $212.35 million, a P/E ratio of -8.86 and a beta of 2.31.

Alpha Cognition (NASDAQ:ACOG) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.01). Alpha Cognition had a negative return on equity of 54.60% and a negative net margin of 153.61%.The business had revenue of $6.00 million for the quarter, compared to analyst estimates of $4.38 million. Analysts predict that Alpha Cognition Inc. will post -1.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Alpha Cognition

Several institutional investors and hedge funds have recently made changes to their positions in the business. Geode Capital Management LLC bought a new stake in Alpha Cognition in the second quarter worth approximately $112,000. Massar Capital Management LP acquired a new stake in shares of Alpha Cognition during the 2nd quarter worth approximately $116,000. Two Sigma Investments LP acquired a new stake in shares of Alpha Cognition during the 3rd quarter worth approximately $148,000. Connective Capital Management LLC bought a new stake in shares of Alpha Cognition in the 3rd quarter valued at $312,000. Finally, ACT Capital Management LLC bought a new stake in shares of Alpha Cognition in the 4th quarter valued at $335,000.

Analysts Set New Price Targets

A number of research firms have commented on ACOG. Wall Street Zen upgraded Alpha Cognition from a “sell” rating to a “hold” rating in a research report on Saturday, August 15th. HC Wainwright lifted their price objective on Alpha Cognition from $18.00 to $20.00 and gave the stock a “buy” rating in a research note on Monday, August 17th. Maxim Group began coverage on Alpha Cognition in a report on Friday, May 29th. They issued a “buy” rating and a $12.00 target price on the stock. Raymond James Financial began coverage on shares of Alpha Cognition in a report on Friday, July 10th. They set an “outperform” rating and a $20.00 price target for the company. Finally, B. Riley Financial assumed coverage on shares of Alpha Cognition in a research report on Thursday, August 20th. They issued a “buy” rating and a $21.00 price target on the stock. Five analysts have rated the stock with a Buy rating, According to MarketBeat, Alpha Cognition currently has an average rating of “Buy” and a consensus target price of $18.00.

About Alpha Cognition

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.